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Abstract
Background: Conventional spirometric parameters have shown poor correlation with symptoms and health status of
chronic obstructive pulmonary disease (COPD). While it is well-known that the pattern of the expiratory flow-volume
curve (EFVC) represents ventilatory dysfunction, little attempts have been made to derive quantitative parameters by
analyzing the curve. In this study, we aimed to derive useful parameters from EFVC via graphic analysis and tried to
validate them in patients with COPD.
Methods: Using Graphical Analysis 3.4 Vernier Software, we derived from the EFVC such parameters as area of
obstruction (Ao), area of triangle (AT), area of rectangle (AR) and ratio of volume at 75 and 25 % peak expiratory flow
(PEF) (0.25/0.75 V). For validation, we reviewed clinical and spirometric data of 61 COPD patients from Seoul National
University Airway Registry (SNUAR) and Korean obstructive Lung Disease (KOLD) cohorts.
Results: Of all parameters, only RV/TLC significantly correlated with scores from St. George’s Respiratory Questionnaire
(SGRQ) (r = 0.447, p = 0.037). Six-minute walking distance (6MWD) highly correlated with Ao/AR
(r = −0.618, p = 0.005) and Ao/PEF (r = −0.581, p = 0.009) whereas neither FEV1 nor FEV1/FVC had significant correlation
with 6MWD.
Conclusions: Ao/AR and Ao/PEF are promising parameters which correlate well with the exercising capacity of COPD
patients.
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Background
Chronic obstructive lung disease (COPD) is defined as
having airflow limitation, measured as forced expiratory
volume in one second (FEV1) divided by forced vital
capacity (FVC). These conventional spirometric parame-
ters, such as FEV1 or FVC, are currently accepted stan-
dards in grading the severity of airflow limitation; when
FEV1/FVC is less than 0.70, diagnosis of COPD is made.
However, these parameters cannot exactly determine
the health status of patients with COPD. For example,
FEV1 shows weak association with physical activity and
subjective symptom scores such as St. George’s Respira-
tory Questionnaire (SGRQ) [1–3]; little correlation
between FEV1 and hospital readmission in such patients
is also reported [4]. Therefore, dyspnea scores and ob-
jectively measured exercise capacity should also be con-
sidered and taken into account.
Exercise capacity, which can be simply measured by 6-
min walking distance (6MWD), is reflective of activities
of daily living and functional status of patients with
COPD but shows poor correlation with FEV1 or FEV1/
FVC [5, 6].
While it is well-known that the concave shape of ex-
piratory flow-volume curve (EFVC) is suggestive of the
presence of underlying small airway obstruction, few at-
tempts have been made to quantify the concave area and
correlate it with clinical indices in patients with COPD
[7–9]. In this study, we sought to derive new useful
graphic parameters from a commonly used spirometric
curve and performed correlation analysis with symptom
severity and exercise capacity. We initially hypothesized
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that the concave area under the flow-volume curve
might reflect symptom severity and health status in pa-
tients with COPD.
Methods
Study subjects and general methods
The following study was approved by the institutional
review board of Seoul National University Bundang Hos-
pital (B-1108/134-004 and B-0508-023-009). Informed
written consent for participation in the study was ob-
tained from all participants.
For validation of new graphic parameters, we analyzed
the clinical and baseline pre-bronchodilator best spiro-
metric data of 61 COPD patients from the Seoul Na-
tional University Airway Registry (SNUAR) and the
Korean Obstructive Lung Disease (KOLD) cohort [10].
40 patients from SNUAR and 21 patients from KOLD
cohort were included in the analysis. The SNUAR cohort
included stable COPD patients who were prospectively
recruited from the outpatient pulmonary clinic of Seoul
National University Bundang Hospital. The diagnosis of
COPD was made according to the Global Initiative for
Chronic Obstructive Lung Disease (GOLD) 2003 cri-
teria. The KOLD cohort consisted of patients with stable
COPD, who were prospectively recruited from the
pulmonary clinics of 11 hospitals in Korea from June
2005 to September 2009.
Spirometry was performed using a Vmax 22 instru-
ment (Sensor-Medics; Yorba Linda, CA, USA). Lung
volumes were measured by body plethysmography
(V6200; SensorMedics). Diffusing capacity for carbon
monoxide (DLco) was measured by the single-breath
method using a Vmax229D (Sensor-Medics). All pul-
monary function tests were performed as recommended
by the American Thoracic Society and European Re-
spiratory Society.
Graphic analysis methods
For graphic analysis of the EFVC, we used Graphical
Analysis 3.4 Vernier Software program. Using the pro-
gram, we first integrated the area under the curve. Fig-
ure 1 shows an example of pre-bronchodilator best
EFVC and integration of the area under the curve using
the software.
Figure 2 shows the lighted area below the imaginary
diagonal line and above the EFVC; we defined this area
as Au, which reflects concavity of the curve. Our new
graphic parameter, Area of obstruction (Ao) and area of
triangle (At) were calculated as follows.
Fig. 1 An example of maximal expiratory flow-volume curve and integration of the area under the curve
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Ao ¼ Au=At
At ¼ PEFR FVC–Xpð Þ=2
As Ao approaches to 1, the concavity of EFVC be-
comes more severe. As Ao gets closer to 0, the EFVC
becomes less concave. Xp denotes the lung volume at
PEFR.
Because the baseline pulmonary function depends on
the patients’ heights and other factors, we needed to de-
fine Ao in ratio rather than raw values. In order to cali-
brate and adjust for such individual differences, we
divided Au by At. Using a raw value such as Au may re-
sult in wrong direction and inappropriate interpretation
of result (see Additional file 1: Table S1).
Another parameter, area of rectangle (AR) were de-
fined as follows; we used the reference equation derived
from the Korea National Health and Nutrition Examina-
tions Survey IV to calculate predicted FVC in Korean
COPD patients [11, 12].
AR ¼ actual PEFR=predicted PEFRð Þ
 actual FVC=predicted FVCð Þ  100%
The ratio of lung volumes at 75 and 25 % of PEFR
(0.25/0.75 V) were also calculated.
Statistical analysis
Statistical analysis was performed using the statistics
software, PASW Statistics for Windows, Version 18.0,
Chicago: SPSS Inc. The association between clinical and
spirometric parameters was determined by using Pear-
son correlation analysis.
Results
The demographic, clinical, and conventional spirometric
characteristics are shown in Table 1. Data are presented
as mean ± SD. The patients were mostly men (96.7 %)
with mean age of 71 years old, 44 pack-years of smoking
history and mean body mass index (BMI) of 23.4 kg/m2.
Mean FEV1 was 65 % and FEV1/FVC 0.48.
Among 61 subjects, the pre-bronchodilator EFVC data
for three subjects were missing, so they were excluded
in the correlation analysis. Table 2 displays the correl-
ation result between clinical and known spirometric pa-
rameters after adjusting for age, BMI and smoking. Of
all conventional parameters, only residual volume (RV)
divided by total lung capacity (TLC) significantly corre-
lated with SGRQ (r = 0.447, p = 0.037). Inspiratory cap-
acity (IC), as percent predicted, showed positive
correlation with 6MWD.
The results for new parameters derived from EFVC
are given in Table 3. The new graphic parameters signifi-
cantly correlated with RV/TLC were Ao, Ao/FVC, Ao/
AR, and Ao/PEF.
Fig. 2 Graphic explanation of new parameters. Au was defined as the lighted area below the imaginary diagonal line and above the expiratory
flow-volume curve. Area of obstruction (Ao) and area of triangle (At) were calculated as follows. Xp denotes the expirated lung volume at PEFR.
The ratio of lung volumes at 75 and 25 % of PEFR (0.25/0.75 V) were also measured. Area of rectangle (AR), not shown here, was defined as
follows. Ao = Au/At; At = PEFR × (FVC–Xp)/2; AR = (actual PEFR/predicted PEFR) × (actual FVC/predicted FVC) × 100 %
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Among clinico-physiological parameters, 6MWD
highly correlated with Ao/AR (r = −0.618, p = 0.005) and
Ao/PEF (r = −0.581, p = 0.009). Neither FEV1 nor FEV1/
FVC had significant correlation with 6MWD.
Discussion
We set out to determine whether new parameters could
further reflect the clinical status of patients with COPD. In
this study, we demonstrated that Ao/AR and Ao/PEF sig-
nificantly negatively correlated with 6MWD. 6MWD is a
simple, objective test of measuring functional capacity tar-
geted at people with at least moderately severe impairment
and can be used as a follow-up tool to show response after
intervention. In addition, the new parameters, Ao/AR and
Ao/PEF, highly correlated with RV/TLC, which is a meas-
ure of hyperinflation. On the other hand, conventional pa-
rameters, such as FEV1 or FEV1/FVC, did not show
correlation with 6MWD in our study.
Most of previous studies sought to derive parameters
reflecting concavity of the EFVC, but did not further in-
vestigate the correlation with clinical and functional in-
dices. Mead et al. first developed the slop ratio as an
index of the curvature of maximal EFVC, but it was
regarded impractical to use [13]. Afterwards, studies
conducted in asthma patients revealed that the concave
shape of the curve became less bowed after the steroid
treatment [14]; the relationship between the severity of
wheezing and the concavity of EFVC was also suggested
[15, 16]. In order to quantify the concavity, Vermaak et
al. attempted to measure the area under the curve (Aex)
as an imaginary triangle with FVC as the base, PEF the
perpendicular axis, and straight descending portion of
maximal EFVC as the hypotenuse, that seemed to be the
most sensitive index to assess the degree of bronchodila-
tion in patients with COPD [17, 18].
More recently, Nozoe et al. studied spontaneous ex-
piratory (SEFV) curve of 34 stable COPD patients at
resting state and found that the area under the curve
divided by the surrounding rectangular area, the rect-
angular area ratio (RAR), is indicative of concavity of
SEFV curve; FEV1 was the most powerful predictor of
concavity of the curve [19]. Ma et al. also used the
same parameter, RAR, in analysis of SEFV curve dur-
ing exercise [20]. While RAR is an excellent novel
parameter to measure concavity of the EFVC, these
studies did not provide the data showing the relation-
ship of RAR with symptom severity and exercise cap-
acity. Another interesting pilot study by Williams
et al. investigated tidal flow-time and flow-volume
centroids of spirograms, which showed shorter time
to reach PEF and more left-shifted centroid pattern in
patients with COPD [21]. Assessing SEFV curve as in
this recent study seems promising and is more applic-
able to elderly patients with comorbidities who can-
not perform the maximal EFVC. Nevertheless,
utilization of SEFV curve is not widely accepted yet
in practice as much as the maximal EFVC. Future
studies are warranted in examining SEFV curve to
check the relationship between new parameters and
functional indices.
Table 1 Clinical characteristics and conventional spirometric
values of patients
Mean (SD or %) N
Age 71 (8) 61
Male 59 (96.7)
BMI (kg/m2) 23.40 (3.40) 56
Smoking (pack-years) 44 (19) 59
FEV1/FVC 0.48 (0.12) 60
FEV1 (%) 65 (18) 60
DLco (%) 73 (20) 59
RV/TLC (%) 0.42 (0.11) 57
RV (%) 113 (43) 58
IC (L) 1.98 (0.56) 56
SGRQ (raw score) 1112 (571) 38
6MWD (m) 425 (126) 31
CAT 12.7 (7.7) 41
Abbreviations: BMI body mass index, FEV1 forced expiratory volume in one
second, FVC forced vital capacity, DLco diffusing capacity for carbon
monoxide, RV residual volume, TLC total lung capacity, IC inspiratory capacity,
SGRQ St. George’s respiratory questionnaire, 6MWD six-minute walking
distance, CAT the chronic obstructive pulmonary disease assessment test
Table 2 Correlation analysis of traditional spirometric parameters and selected variables
FEV1 FEV1/FVC RV/TLC PEF IC
r a P-value r a P-value r a P-value r a P-value r a P-value
RV/TLC −0.881 * <0.001 −0.702 * <0.001 – – −0.765 * <0.001 −0.148 0.512
SGRQ −0.355 0.105 −0.140 0.534 0.447 * 0.037 −0.306 0.202 −0.073 0.747
6MWD 0.201 0.371 0.042 0.853 −0.257 0.249 0.441 0.058 0.611 * 0.003
CAT −0.226 0.313 −0.026 0.909 0.277 0.213 −0.233 0.337 −0.046 0.838
Abbreviations: FEV1 forced expiratory volume in one second, FVC forced vital capacity, RV residual volume, TLC total lung capacity, IC inspiratory capacity, PEF peak
expiratory flow, SGRQ St. George’s respiratory questionnaire, 6MWD 6-min walking distance, CAT the chronic obstructive pulmonary disease assessment test
ar: Pearson’s correlation coefficient, adjusted for age, BMI and smoking
*P-value < 0.05
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The authors acknowledge that the present study
has several limitations. First, the size of study sample
was too small to fully validate our new parameters.
Second, we analyzed the pre-bronchodilator best ex-
piratory curves rather than the post-bronchodilator
curves, which could have affected the curvature.
Third, most patients were in moderate to severe
stage of COPD, GOLD II-III, and we did not include
the patients with mild COPD (FEV1 ≥ 80 %).
Conclusion
In this study, we found that Ao/AR and Ao/PEF are
potentially useful parameters which correlate well
with exercising capacity in patients with COPD. Yet,
further studies are warranted to validate the new pa-
rameters in a sample of sufficient size and also in
SEFV curves.
Additional file
Additional file 1: Table S1 Correlation analysis between Au and
selected variables. Pearson correlation coefficients are shown in the left
column with p-values in the right column. (DOC 30 kb)
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